Ersefuril caps 200mg #28

Ersefuril instruction for use

You can buy Ersefuril here

Ersefuril is a drug that is used to treat acute bacterial diarrhea. The agent is administered in the form of capsules intended for oral administration. The active substance in the medicine is nifuroxazide. This component produces antibacterial action. Ersefuril is not prescribed for pregnant women and children under 3 years of age.

Dosage form

The drug Ersefuril is sold in the form of capsules intended for oral use. The drug is dispensed in contour cell packs, each containing 14 units of the drug. Then blisters (1 piece or 2) are placed in packs of cardboard.

Description and composition

Ersefuril is gelatin capsules, solid, have a yellow body, the size of the units of preparation No. 1. Inside is a powder, also characterized by a yellow tinge.
The active component of the medication Ersefuril is nifuroxazide in a dosage of 200 mg per capsule.
Also in the composition of the medicine there are a number of components acting in the role of auxiliary, they include:
    corn starch;
    magnesium stearate;
    sucrose.
The substances listed above are in the powder composition inside. The capsule itself consists of the following components:
    gelatin;
    dye (yellow ferric oxide);
    titanium dioxide.

Pharmacological group

The main action is antimicrobial. The drug is classified as antidiarrhoeal agents, intestinal antiseptics.
Nifuroxazide is a derivative of nitrofuran. The action of the substance is aimed at blocking the dehydrogenase activity and inhibiting the respiratory chains, the cycle of tricarboxylic acids and other processes in the microbial cell. The main constituent of Ersefuril also has a destructive effect on the cell membrane of the microbe and reduces the formation of toxins by microorganisms. Nifuroxazide is highly active in the fight against Campylobacter jejuni, Escherichia coli, Salmonella spp., Shigella spp., Clostridium perfringens, Vibrio cholerae, Vibrions and Vibrio parahaemolytique, Staphylococcus spp.
The following microorganisms exhibit less severe sensitivity to nifuroxazide: Citrobacter spp., Enterobacter cloacae and Proteus indologenes.
The microorganisms listed below, and do resist at all to the active component of the agent Ersefuril:
    Klebsiella spp .;
    Pseudomonas spp;
    Proteus mirabilis;
    Providencia spp.
When Ersefuril is used, there is no imbalance in the microflora in the intestine. In the case of therapy of bacterial diarrhea, nifuroxazide normalizes the killing eubiosis. When infectious infection with enterotrial viruses acts as an obstacle to the development of superinfection of the bacterial series.
Absorption of nifuroxazide from the digestive tract practically does not occur, the manifestation of antibacterial properties of the drug is noted only in the lumen of the intestine. Excretion occurs through the intestine, 20% of the substance remains in its original form, and the rest remains in the altered one.

Indications for use

The drug Ersefuril is used to combat disorders that require antibacterial measures in the intestine.

For adults

For adults, the indication for the use of the drug is bacterial diarrhea of ​​an acute nature, which proceeds without a marked deterioration in the patient's state of health, without excessive temperature and intoxication.

For children

The drug Ersefuril is prescribed exclusively to patients older than 3 years.
For children older than the same indication for use, as for adult patients.

For pregnant and lactating

Despite the lack of data on the negative effect of the main component of the drug on the fetus, Ersefuril is not recommended for use in pregnant women. This fact is due to the fact that a sufficient number of studies have not been conducted to determine the effect of the medication on the organism of a woman bearing a child. In the lactation period, very short courses of treatment with nifuroxazide, prescribed by a doctor, are possible.

Contraindications

In the presence of some factors, the use of medication Ersefuril in a patient is impossible. Such categories of patients include pregnant women, children whose age does not exceed three years, as well as patients with increased individual sensitivity or intolerance to the components of the remedy.
Due to the presence of sucrose in patients with intolerance to fructose, deficiency of sugar and isomaltase, as well as with glucose-galactose malabsorption syndrome, Ersefuril is not prescribed.

Dosing and Administration

Ersefuril capsules are for oral use. The duration of the course of therapy, as a rule, is from 5 to 7 days. At the same time, if the waiting period for the occurrence of positive effects from treatment exceeds three days, you need to contact a medical institution.

For adults

Adult patients take medication four times a day at regular intervals of 6 hours. Single dose is 1 capsule (200 mg) of nifuroxazide.

For children

Children prescribed in reduced dosages. For patients aged 3 to 6 years, the following dosing regimen: 3 times a day for one capsule (the interval of admission is 8 hours). Children 6 to 18 years of age receive one capsule three or four times a day at the physician's discretion.

For pregnant and lactating

Women who are in a state of carrying a child are not recommended to use the drug Ersefuril.
In case of necessity of reception at a lactemia the dosage for the nursing patient is established by the doctor.

Side effects of Ersefuril

Among the clinical manifestations that can occur with the use of capsules Ersefuril, are the following:
    hives;
    anaphylactic shock.
    angioedema;
    rashes on the skin;

Interaction with other drugs

It is necessary to avoid the joint administration of the drug Ersefuril with medications that provoke the emergence of disulfiram-like reactions, as well as with those that depress the function of the central nervous system.

special instructions

When using therapy with the drug Ersefuril, you need to carry out rehydration procedures.
The emergence of additional negative clinical manifestations in the form of deterioration of the body, high fever, symptoms of intoxication or other effects necessitates the need to seek advice from the treating specialist, it is possible to change the tactics of therapy or the use of antibacterial agents of systemic exposure.
The appearance of allergic reactions requires immediate withdrawal of the drug.
During therapy with the drug Ersefuril, it is unacceptable to drink alcoholic beverages.
The composition of the drug is sucrose, which must be taken into account when performing therapy in patients with diabetes mellitus.
The drug Ersefuril does not have any effect on the ability of individuals to exercise control mechanisms and devices (including vehicles) that require intensive use of the patient's cognitive abilities, as well as a high level of the speed of psychomotor series reactions.

Overdose

The occurrence of an overdose of Ersefuril has not been described. However, in case of taking the drug in a dosage that is excessively exceeding the recommended side effects may worsen. In such situations, symptomatic treatment is used.

Storage conditions

Keep the drug Ersefuril in a dry place, inaccessible to children and protected from direct sunlight. The storage temperature is room temperature.
The medication remains eligible for 5 years from the date of its release. It is inadmissible to use the drug after the expiration of the specified period.
The release of Ersefuril their pharmacies is carried out without prescription.

Terms of sell

You don't need a prescription to buy Ersefuril.